Tibsovo(ivosidenib)
TIBSOVO 250 MG Oral Tablet

Dosage & Administration

Dosage & Administration

500 mg orally once daily with or without food until disease progression or unacceptable toxicity . Avoid a high-fat meal.

Most viewed Tibsovo resources

Enroll in Patient Savings Program

drug label

Tibsovo Prescribing Information

prior authorization

Tibsovo Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Jun 26, 2024Arizona - Uniform Prior Authorization Form
Verified: Jun 26, 2024Colorado - Uniform Prior Authorization Form
Verified: Jun 26, 2024Hawaii - Uniform Prior Authorization Form
Verified: Jul 26, 2024Illinois - Uniform Prior Authorization Form
Verified: Jun 26, 2024Indiana - Uniform Prior Authorization Form
Verified: Jun 26, 2024Louisiana - Uniform Prior Authorization Form
Verified: Jun 26, 2024Minnesota - Uniform Prior Authorization Form
Verified: Jun 26, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Jun 26, 2024New Mexico - Uniform Prior Authorization Form
Verified: Jun 26, 2024Oregon - Uniform Prior Authorization Form
Verified: Jun 26, 2024Texas - Uniform Prior Authorization Form
Verified: Jul 07, 2024Washington - Uniform Prior Authorization Form
Verified: Jul 07, 2024Wisconsin - Uniform Prior Authorization Form

Benefits investigation

Servier One Enrollment Form

pharmacy

Tibsovo Preferred Pharmacy

Pharmacy List

financial assistance

Tibsovo Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program
Learn More

Bridge program

Servier One Enrollment Form
Bridge Program - Max 2 Month Supply
Learn More

Foundation programs

Servier One Enrollment Form
Patient Assistance Program
Learn More

patient education

Tibsovo Patient Education

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

Other Patient Resources - Servier ONE for Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Acute Myeloid Leukemia (AML) Factsheet
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Cholangiocarcinoma (CCA) Factsheet
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Tibsovo: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Tibsovo: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Tibsovo: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Tibsovo: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

people also ask

Tibsovo FAQs

How is the dosage of Tibsovo?Tibsovo is available in 1 dosages, including 250 mg Tab
What does Tibsovo treat?Tibsovo treats Acute Myeloid Leukemia
What is Tibsovo made of?Tibsovo contains ivosidenib which is a Isocitrate Dehydrogenase 1 Inhibitor
How Is Tibsovo Administered?Tibsovo is administered as a Oral Pill
What Are The Tibsovo Mechanism Of Action?Tibsovo mechanism of action is Cytochrome P450 2C9 Inducers, Cytochrome P450 3A4 Inducers or Isocitrate Dehydrogenase 1 Inhibitors
FAQ Data Source